1322 Engineering genetic devices for in vivo control of therapeutic T cell activity triggered by the dietary molecule resveratrol.
https://www.pnas.org/content/118/34/e2106612118
1321 An in vivo selection-derived d-peptide for engineering erythrocyte-binding antigens that promote immune tolerance.
https://www.pnas.org/content/118/34/e2101596118
1320 Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths.
https://immunology.sciencemag.org/content/6/62/eabl4340
1319 Systems vaccinology of the BNT162b2 mRNA vaccine in humans.
https://www.nature.com/articles/s41586-021-03791-x
1318 Protective efficacy of Ad26.COV2.S against SARS-CoV-2 B.1.351 in macaques.
https://www.nature.com/articles/s41586-021-03732-8
1317 Soluble mannose receptor induces proinflammatory macrophage activation and metaflammation.
https://www.pnas.org/content/118/31/e2103304118
1316 Nasal delivery of an IgM offers broad protection from SARS-CoV-2 variants.
https://www.nature.com/articles/s41586-021-03673-2
1315 Skull and vertebral bone marrow are myeloid cell reservoirs for the meninges and CNS parenchyma.
https://science.sciencemag.org/content/373/6553/eabf7844
1314 A resident stromal cell population actively restrains innate immune response in the propagation phase of colitis pathogenesis in mice.
https://stm.sciencemag.org/content/13/603/eabb5071
1313 BNT162b2 vaccine induces neutralizing antibodies and poly-specific T cells in humans.
https://www.nature.com/articles/s41586-021-03653-6
|
